Literature DB >> 18818706

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.

L J Russell, D G De Castro, M Griffiths, N Telford, O Bernard, R Panzer-Grümayer, O Heidenreich, A V Moorman, C J Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818706     DOI: 10.1038/leu.2008.250

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  20 in total

Review 1.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

2.  Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Authors:  Shalini C Reshmi; Richard C Harvey; Kathryn G Roberts; Eileen Stonerock; Amy Smith; Heather Jenkins; I-Ming Chen; Marc Valentine; Yu Liu; Yongjin Li; Ying Shao; John Easton; Debbie Payne-Turner; Zhaohui Gu; Thai Hoa Tran; Jonathan V Nguyen; Meenakshi Devidas; Yunfeng Dai; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Anne L Angiolillo; Michael J Burke; Wanda L Salzer; Patrick A Zweidler-McKay; Karen R Rabin; William L Carroll; Jinghui Zhang; Mignon L Loh; Charles G Mullighan; Cheryl L Willman; Julie M Gastier-Foster; Stephen P Hunger
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

3.  IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia.

Authors:  Sally J Jeffries; Lisa Jones; Christine J Harrison; Lisa J Russell
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

4.  A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

Authors:  Moneeb A K Othman; Beata Grygalewicz; Barbara Pienkowska-Grela; Jolanta Rygier; Anna Ejduk; Martina Rincic; Joana B Melo; Isabel M Carreira; Britta Meyer; Thomas Liehr
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

Review 5.  Understanding the biology of CRLF2-overexpressing acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; Mignon L Loh
Journal:  Crit Rev Oncog       Date:  2011

6.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Ryan D Morin; Jinghui Zhang; Martin Hirst; Yongjun Zhao; Xiaoping Su; Shann-Ching Chen; Debbie Payne-Turner; Michelle L Churchman; Richard C Harvey; Xiang Chen; Corynn Kasap; Chunhua Yan; Jared Becksfort; Richard P Finney; David T Teachey; Shannon L Maude; Kane Tse; Richard Moore; Steven Jones; Karen Mungall; Inanc Birol; Michael N Edmonson; Ying Hu; Kenneth E Buetow; I-Ming Chen; William L Carroll; Lei Wei; Jing Ma; Maria Kleppe; Ross L Levine; Guillermo Garcia-Manero; Eric Larsen; Neil P Shah; Meenakshi Devidas; Gregory Reaman; Malcolm Smith; Steven W Paugh; William E Evans; Stephan A Grupp; Sima Jeha; Ching-Hon Pui; Daniela S Gerhard; James R Downing; Cheryl L Willman; Mignon Loh; Stephen P Hunger; Marco A Marra; Charles G Mullighan
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

7.  Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.

Authors:  Ilaria Iacobucci; Yongjin Li; Kathryn G Roberts; Stephanie M Dobson; Jaeseung C Kim; Debbie Payne-Turner; Richard C Harvey; Marcus Valentine; Kelly McCastlain; John Easton; Donald Yergeau; Laura J Janke; Ying Shao; I-Ming L Chen; Michael Rusch; Sasan Zandi; Steven M Kornblau; Marina Konopleva; Elias Jabbour; Elisabeth M Paietta; Jacob M Rowe; Ching-Hon Pui; Julie Gastier-Foster; Zhaohui Gu; Shalini Reshmi; Mignon L Loh; Janis Racevskis; Martin S Tallman; Peter H Wiernik; Mark R Litzow; Cheryl L Willman; John D McPherson; James R Downing; Jinghui Zhang; John E Dick; Stephen P Hunger; Charles G Mullighan
Journal:  Cancer Cell       Date:  2016-02-08       Impact factor: 31.743

8.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

9.  T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Authors:  Heather Rogers; Li Wang; Xiaobing Yu; Mawadda Alnaeeli; Kairong Cui; Keji Zhao; James J Bieker; Josef Prchal; Suming Huang; Babette Weksler; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-09-16       Impact factor: 5.157

10.  Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.

Authors:  Kenichi Sakamoto; Seiji Tanaka; Chihiro Tomoyasu; Toshihiro Tomii; Mio Yano; Kazutaka Takagi; Tsutsumi Yasuhiko; Nobuhiko Uoshima; Hiroshi Komatsu; Toshihiko Imamura
Journal:  Int J Hematol       Date:  2016-08-20       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.